 |
|
Empiric Treatment of Fungal Infections in the Neutropenic HostReview of the Literature and Guidelines for Use
Alan M. Sugar, MD
Arch Intern Med. 1990;150(11):2258-2264.
Abstract
• Persistent fever that is refractory to broad-spectrum antibacterials is common in neutropenic patients undergoing induction chemotherapy of acute leukemia. Clinical experience suggests that many of these patients are infected with fungi. Until recently, data supporting the role of empiric antifungal therapy in this setting were limited to small groups of patients or postmortem reports. Evolving evidence in larger patient populations supports data from smaller series: febrile neutropenic patients who have failed to respond to a 4- to 7-day course of broad-spectrum antibacterials may benefit from the early initiation of antifungal therapy. Patients with fungal colonization or pulmonary infiltrates and adult patients who have not received previous fungal prophylaxis may especially benefit from the early use of antifungal drugs. Amphotericin B has been the "gold standard" for empiric antifungal therapy, although the newer azoles may be useful in certain situations.
(Arch Intern Med. 1990;150:2258-2264)
Author Affiliations
From the Evans Memorial Department of Clinical Research, The University Hospital, and Thorndike Memorial Laboratory, Department of Medicine, Boston (Mass) City Hospital.
Footnotes
Accepted for publication May 22,1990.
Reprint requests to The University Hospital, E-540, 88 E Newton St, Boston, MA 02118 (Dr Sugar).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Improving Efficacy of Antifungal Therapy by Polymerase Chain Reaction-Based Strategy among Febrile Patients with Neutropenia and Cancer
Lin et al.
Clinical Infectious Diseases 2001;33:1621-1627.
ABSTRACT
| FULL TEXT
A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy
Erjavec et al.
J Antimicrob Chemother 2000;45:843-849.
ABSTRACT
| FULL TEXT
Rashes in Immunocompromised Cancer Patients: The Diagnostic Yield of Skin Biopsy and Its Effects on Therapy
Chren et al.
Arch Dermatol 1993;129:175-181.
ABSTRACT
|
